MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Effects of Transpinal Magnetic Stimulation (TsMS) in Patients Diagnosed with Spinocerebellar Ataxia 3 (SCA 3)

    K. Silveira Massruha, R. Bernhart Carra, J. Simões, G. Nunes Simões, J. Reis Menezes, V. Zanesi Maciel, M. Belo Silva, P. Medeiros Lacerda, T. Gonçalves Guimarães, E. Reis Barbosa, R. Gisbert Cury (São Paulo, Brazil)

    Objective: Ataxia is a neurological condition characterized by impaired coordination, balance, and motor control. While physiotherapy remains a cornerstone in SCA 3 management, emerging therapies such…
  • 2024 International Congress

    Superficial siderosis; a case review

    ANM. Afifi, L. Satke, E. čecháková (Olomouc, Czech Republic)

    Objective: To highlight an often overlooked cause of ataxia with hearing impairment. Background: Superficial siderosis (SS) of the nervous system is caused by chronic hemosiderin…
  • 2024 International Congress

    Seminoma resulting in rapidly progressive cerebellar syndrome with associated dual positive kelch-like protein 11 (KLHL11) IgG and leucine zipper 4 (LUZP4)–immunoglobulin G (IgG) antibodies.

    R. Orie, V. Suski, G. Quiroga-Garza, J. Linnoila (Pittsburgh, USA)

    Objective: We describe a case of retroperitoneal seminoma resulting in paraneoplastic progressive cerebellar syndrome secondary to KLHL11 and LUZP4 antibodies. Background: Testicular cancer covers a…
  • 2024 International Congress

    Clinico-radiological and genetic profile of patients with Ataxia with Oculomotor apraxia type-2 (AOA2)- A case series from India

    M. Chandarana, B. Tilva, A. Agarwal, D. Garg (Ahmedabad, India)

    Objective: To delineate clinical, radiological and genetic profile of patients with ataxia with oculomotor apraxia type-2 (AOA2) in Indian cohort. Background: AOA2 is a relatively…
  • 2024 International Congress

    An Unusual and Treatable Cause of Cerebellar Ataxia and Dystonia: Homozygous COQ4 Gene Mutation

    T. Coradine, M. Soares, P. Fraiman, L. Corazza, T. Silva, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)

    Objective: To report a case of Coenzyme Q10 (CoQ10) deficiency due to COQ4 variants causing adult-onset ataxia and dystonic postures. Background: CoQ10 is an essential…
  • 2024 International Congress

    Electrophysiological study of 122 Tunisian patients with autosomal recessive cerebellar ataxia

    L. Hlioui, R. Zouari, R. Amouri, MZ. Saied, D. Ben Mohamed, A. Rachdi, S. Ben Sassi (Tunis, Tunisia)

    Objective: We aim through this study to describe the electrophysiological features of the different Autosomal recessive cerebellar ataxias (ARCA) in our population in order to…
  • 2024 International Congress

    Gait and turning during daily life across the spectrum of normal, prodromal, early and moderate Parkinson’s disease

    M. Mancini, V. Shah, P. Burgos, P. Carlson-Kuhta, L. Talman, M. Lim, J. Quinn, F. Horak (Portland, USA)

    Objective: To compare gait and turning quality during daily life in older adults, people with Rapid Eye Movement (REM) sleep behavior disorder (RBD) and people…
  • 2024 International Congress

    A Conversational GPT Agent for Parkinson’s Disease

    B. Várkuti, L. Manola, M. Atayi, L. Liemen, G. van Elswijk, F. Lange, M. Reich, L. Erōss, M. Okun, J. Volkmann (München, Germany)

    Objective: To create a conversational chat agent that can provide persons with Parkinson’s with information about their disease. Background: Artificial intelligence using Large Language Models…
  • 2024 International Congress

    Characterization of a Novel alpha-synuclein PET radiotracer, [18F]C05-05, in a PPMI Sub-study

    D. Russell, C. Constantinescu, R. Gunn, J. Eberling, A. Lorenzo, M. Rowland, S. Roman, J. Seibyl, K. Marek, MJF. Imaging Consortium, THE. Ppmi Study (New Haven, USA)

    Objective: Characterization of the PET radiotracer, [18F]C05-05, in the PPMI Study Background: Validation of imaging biomarkers in Parkinson disease (PD) is a major objective of…
  • 2024 International Congress

    Relationships of blood Vitamin B12 and Homocysteine with Parkinson’s Disease Progression in 3 Contemporary Clinical Trials

    C. Christine, P. Auinger, E. Forti, L. Tat, N. Cannizzaro, D. Oakes, R. Green (San Francisco, USA)

    Objective: To measure blood levels of vitamin B12 and homocysteine (tHcy) in contemporary clinical trial participants and to determine whether these analytes were associated with…
  • « Previous Page
  • 1
  • …
  • 460
  • 461
  • 462
  • 463
  • 464
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley